Plasminogen deficiency does not prevent sodium retention in a genetic mouse model of experimental nephrotic syndrome

Standard

Plasminogen deficiency does not prevent sodium retention in a genetic mouse model of experimental nephrotic syndrome. / Xiao, Mengyun; Bohnert, Bernhard N; Aypek, Hande; Kretz, Oliver; Grahammer, Florian; Aukschun, Ute; Wörn, Matthias; Janessa, Andrea; Essigke, Daniel; Daniel, Christoph; Amann, Kerstin; Huber, Tobias B; Plow, Edward F; Birkenfeld, Andreas L; Artunc, Ferruh.

In: ACTA PHYSIOL, Vol. 231, No. 1, e13512, 01.2021.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Xiao, M, Bohnert, BN, Aypek, H, Kretz, O, Grahammer, F, Aukschun, U, Wörn, M, Janessa, A, Essigke, D, Daniel, C, Amann, K, Huber, TB, Plow, EF, Birkenfeld, AL & Artunc, F 2021, 'Plasminogen deficiency does not prevent sodium retention in a genetic mouse model of experimental nephrotic syndrome', ACTA PHYSIOL, vol. 231, no. 1, e13512. https://doi.org/10.1111/apha.13512

APA

Xiao, M., Bohnert, B. N., Aypek, H., Kretz, O., Grahammer, F., Aukschun, U., Wörn, M., Janessa, A., Essigke, D., Daniel, C., Amann, K., Huber, T. B., Plow, E. F., Birkenfeld, A. L., & Artunc, F. (2021). Plasminogen deficiency does not prevent sodium retention in a genetic mouse model of experimental nephrotic syndrome. ACTA PHYSIOL, 231(1), [e13512]. https://doi.org/10.1111/apha.13512

Vancouver

Bibtex

@article{aefbeea5c7b446c699ba09730bb1673a,
title = "Plasminogen deficiency does not prevent sodium retention in a genetic mouse model of experimental nephrotic syndrome",
abstract = "AIM: Sodium retention is the hallmark of nephrotic syndrome (NS) and mediated by the proteolytic activation of the epithelial sodium channel (ENaC) by aberrantly filtered serine proteases. Plasmin is highly abundant in nephrotic urine and has been proposed to be the principal serine protease responsible for ENaC activation in NS. However, a proof of the essential role of plasmin in experimental NS is lacking.METHODS: We used a genetic mouse model of NS based on an inducible podocin knockout (Bl6-Nphs2tm3.1Antc *Tg(Nphs1-rtTA*3G)8Jhm *Tg(tetO-cre)1Jaw or nphs2Δipod ). These mice were crossed with plasminogen deficient mice (Bl6-Plgtm1Jld or plg-/- ) to generate double knockout mice (nphs2Δipod *plg-/- ). NS was induced after oral doxycycline treatment for 14 days and mice were followed for subsequent 14 days.RESULTS: Uninduced nphs2Δipod *plg-/- mice had normal kidney function and sodium handling. After induction, proteinuria increased similarly in both nphs2Δipod *plg+/+ and nphs2Δipod *plg-/- mice. Western blot revealed the urinary excretion of plasminogen and plasmin in nphs2Δipod *plg+/+ mice which were absent in nphs2Δipod *plg-/- mice. After the onset of proteinuria, amiloride-sensitive natriuresis was increased compared to the uninduced state in both genotypes. Subsequently, urinary sodium excretion dropped in both genotypes leading to an increase in body weight and development of ascites. Treatment with the serine protease inhibitor aprotinin prevented sodium retention in both genotypes.CONCLUSIONS: This study shows that mice lacking urinary plasminogen are not protected from ENaC-mediated sodium retention in experimental NS. This points to an essential role of other urinary serine proteases in the absence of plasminogen.",
author = "Mengyun Xiao and Bohnert, {Bernhard N} and Hande Aypek and Oliver Kretz and Florian Grahammer and Ute Aukschun and Matthias W{\"o}rn and Andrea Janessa and Daniel Essigke and Christoph Daniel and Kerstin Amann and Huber, {Tobias B} and Plow, {Edward F} and Birkenfeld, {Andreas L} and Ferruh Artunc",
note = "{\textcopyright} 2020 Scandinavian Physiological Society. Published by John Wiley & Sons Ltd.",
year = "2021",
month = jan,
doi = "10.1111/apha.13512",
language = "English",
volume = "231",
journal = "ACTA PHYSIOL",
issn = "1748-1708",
publisher = "Wiley-Blackwell",
number = "1",

}

RIS

TY - JOUR

T1 - Plasminogen deficiency does not prevent sodium retention in a genetic mouse model of experimental nephrotic syndrome

AU - Xiao, Mengyun

AU - Bohnert, Bernhard N

AU - Aypek, Hande

AU - Kretz, Oliver

AU - Grahammer, Florian

AU - Aukschun, Ute

AU - Wörn, Matthias

AU - Janessa, Andrea

AU - Essigke, Daniel

AU - Daniel, Christoph

AU - Amann, Kerstin

AU - Huber, Tobias B

AU - Plow, Edward F

AU - Birkenfeld, Andreas L

AU - Artunc, Ferruh

N1 - © 2020 Scandinavian Physiological Society. Published by John Wiley & Sons Ltd.

PY - 2021/1

Y1 - 2021/1

N2 - AIM: Sodium retention is the hallmark of nephrotic syndrome (NS) and mediated by the proteolytic activation of the epithelial sodium channel (ENaC) by aberrantly filtered serine proteases. Plasmin is highly abundant in nephrotic urine and has been proposed to be the principal serine protease responsible for ENaC activation in NS. However, a proof of the essential role of plasmin in experimental NS is lacking.METHODS: We used a genetic mouse model of NS based on an inducible podocin knockout (Bl6-Nphs2tm3.1Antc *Tg(Nphs1-rtTA*3G)8Jhm *Tg(tetO-cre)1Jaw or nphs2Δipod ). These mice were crossed with plasminogen deficient mice (Bl6-Plgtm1Jld or plg-/- ) to generate double knockout mice (nphs2Δipod *plg-/- ). NS was induced after oral doxycycline treatment for 14 days and mice were followed for subsequent 14 days.RESULTS: Uninduced nphs2Δipod *plg-/- mice had normal kidney function and sodium handling. After induction, proteinuria increased similarly in both nphs2Δipod *plg+/+ and nphs2Δipod *plg-/- mice. Western blot revealed the urinary excretion of plasminogen and plasmin in nphs2Δipod *plg+/+ mice which were absent in nphs2Δipod *plg-/- mice. After the onset of proteinuria, amiloride-sensitive natriuresis was increased compared to the uninduced state in both genotypes. Subsequently, urinary sodium excretion dropped in both genotypes leading to an increase in body weight and development of ascites. Treatment with the serine protease inhibitor aprotinin prevented sodium retention in both genotypes.CONCLUSIONS: This study shows that mice lacking urinary plasminogen are not protected from ENaC-mediated sodium retention in experimental NS. This points to an essential role of other urinary serine proteases in the absence of plasminogen.

AB - AIM: Sodium retention is the hallmark of nephrotic syndrome (NS) and mediated by the proteolytic activation of the epithelial sodium channel (ENaC) by aberrantly filtered serine proteases. Plasmin is highly abundant in nephrotic urine and has been proposed to be the principal serine protease responsible for ENaC activation in NS. However, a proof of the essential role of plasmin in experimental NS is lacking.METHODS: We used a genetic mouse model of NS based on an inducible podocin knockout (Bl6-Nphs2tm3.1Antc *Tg(Nphs1-rtTA*3G)8Jhm *Tg(tetO-cre)1Jaw or nphs2Δipod ). These mice were crossed with plasminogen deficient mice (Bl6-Plgtm1Jld or plg-/- ) to generate double knockout mice (nphs2Δipod *plg-/- ). NS was induced after oral doxycycline treatment for 14 days and mice were followed for subsequent 14 days.RESULTS: Uninduced nphs2Δipod *plg-/- mice had normal kidney function and sodium handling. After induction, proteinuria increased similarly in both nphs2Δipod *plg+/+ and nphs2Δipod *plg-/- mice. Western blot revealed the urinary excretion of plasminogen and plasmin in nphs2Δipod *plg+/+ mice which were absent in nphs2Δipod *plg-/- mice. After the onset of proteinuria, amiloride-sensitive natriuresis was increased compared to the uninduced state in both genotypes. Subsequently, urinary sodium excretion dropped in both genotypes leading to an increase in body weight and development of ascites. Treatment with the serine protease inhibitor aprotinin prevented sodium retention in both genotypes.CONCLUSIONS: This study shows that mice lacking urinary plasminogen are not protected from ENaC-mediated sodium retention in experimental NS. This points to an essential role of other urinary serine proteases in the absence of plasminogen.

U2 - 10.1111/apha.13512

DO - 10.1111/apha.13512

M3 - SCORING: Journal article

C2 - 32455507

VL - 231

JO - ACTA PHYSIOL

JF - ACTA PHYSIOL

SN - 1748-1708

IS - 1

M1 - e13512

ER -